Terms: = Uterine cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Staging
3 results:
1. Immunohistochemical Biomarkers of Survival in Patients With Adenocarcinoma of the uterine Cervix Receiving Chemoradiotherapy.
Lin YC; Chen RY; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Chang YY; Chen SW
Anticancer Res; 2019 Jun; 39(6):3231-3240. PubMed ID: 31177173
[TBL] [Abstract] [Full Text] [Related]
2. Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium.
Bircan S; Ensari A; Ozturk S; Erdogan N; Dundar I; Ortac F
Pathol Oncol Res; 2005; 11(1):32-9. PubMed ID: 15800680
[TBL] [Abstract] [Full Text] [Related]
3. Immunohistochemical evaluation is not prognostic for recurrence in fully staged high-risk endometrial cancer.
Fanning J; Brown S; Phibbs G; Kramer T; Zaher A
Int J Gynecol Cancer; 2002; 12(3):286-9. PubMed ID: 12060450
[TBL] [Abstract] [Full Text] [Related]
